镰状细胞病儿童基础免疫系列覆盖率研究
本研究利用密歇根州护理改善登记系统,评估2001-2016年出生儿童在19和35月龄时基础免疫系列完成情况。结果显示镰状细胞病患儿免疫覆盖率高于无病儿童(19月龄58.5% vs 48.0%,35月龄74.7% vs 59.6%),但仍有超过40%患儿在19月龄时未完成全部推荐免疫。建议利用免疫信息系统提高常规免疫覆盖率。
要点
- 镰状细胞病患儿基础免疫系列完成率在19和35月龄均显著高于无病儿童。
- 19月龄时仍有超过40%的镰状细胞病患儿未完成全部推荐免疫。
- 应利用免疫信息系统改善镰状细胞病患儿的常规免疫覆盖。
核心结论
- 镰状细胞病患儿免疫覆盖率高于无病儿童,但19月龄时超过40%未完成全部推荐免疫。
研究设计与样本
- 回顾性队列研究,使用密歇根州护理改善登记系统数据,纳入2001-2016年出生儿童,分析于2019年进行。
主要发现
- 19月龄时免疫系列完成率镰状细胞病患儿为58.5%,无病儿童为48.0%(p<0.0001)。
- 35月龄时免疫系列完成率镰状细胞病患儿为74.7%,无病儿童为59.6%(p<0.0001)。
- 调整医疗补助标识后,镰状细胞病患儿完成系列的比值比在19月龄为1.4(95%CI=1.2,1.6),35月龄为1.7(95%CI=1.5,2.0)。
临床怎么用
- 应利用免疫信息系统识别镰状细胞病患儿并提高其常规免疫覆盖率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Children with sickle cell disease are at increased risk of serious infections, many of which can be prevented by receipt of recommended immunizations. Study objectives were to (1) assess the primary immunization series coverage among children with sickle cell disease and (2) compare the coverage with that of those without sickle cell disease. METHODS: The Michigan Care Improvement Registry was used to obtain primary immunization series doses and sickle cell disease status for all eligible children in Michigan born in 2001-2016 (analysis was conducted in 2019). Completion of series and each individual vaccine were assessed for every child at ages 19 and 35 months. Proportions were stratified by sickle cell disease status and compared using chi-square tests. Logistic regression was used to model the odds of completing the series at each age, as predicted by sickle cell disease status and adjusting for the presence of Medicaid identification number. RESULTS: The proportion of children who completed the immunization series was higher for those with sickle cell disease than for those without sickle cell disease at 19 months (58.5% vs 48.0%) and 35 months (74.7% vs 59.6%) (both p<0.0001). The odds of completing the series were 1.4 times higher at 19 months (95% CI=1.2, 1.6) and 1.7 times higher at 35 months (95% CI=1.5, 2.0) for children with sickle cell disease than for those without, adjusting for the presence of Medicaid identification number. CONCLUSIONS: Although children with sickle cell disease had higher immunization rates than those without sickle cell disease, >40% of children with sickle cell disease did not receive all recommended immunizations by age 19 months. Immunization information systems should be utilized to improve routine immunization coverage of children with sickle cell disease.
引用
- Peng HK, Dombkowski KJ, Freed GL, et al. Primary Immunization Series Coverage of Children With Sickle Cell Disease. Am J Prev Med. 2021. PMID: 33715942. doi:10.1016/j.amepre.2021.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。